About Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia
L'ospedale Infermi è l'ospedale pubblico della città di Rimini, situato a sud della città, ma non lontano dal centro cittadino.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia
During the past decade, Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2014-10-28
2017-07-10
Completed
746
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins
2014-06-01
2015-11-01
Completed
184
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
2014-07-22
2017-06-05
Completed
2,725
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia"
#1 collaborator was "ERIC Group" with 1 trials as a collaborator, "GRADE Onlus" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia
According to Clinical.Site data, the most researched conditions in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia" are
"Acute Myeloid Leukemia" (2 trials), "Chronic Myeloid Leukemia" (2 trials), "Acute Lymphoid Leukemia" (1 trials), "Adults" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia" in a lesser frequency.
Clinical Trials Intervention Types at Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia
Most popular intervention types in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (2 trials), "Chemotherapy" (1 trials), "Consolidation with ADCT-402 (loncastuximab tesirine) after salvage immunochemotherapy (R-BAC, Rituximab - Bendamustine, Ara-C))" (1 trials), "Gemtuzumab Ozogamicin" (1 trials) and "Glasdegib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia
The vast majority of trials in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia" are
18 trials for "All" genders.
Clinical Trials Status at Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia
Currently, there are NaN active trials in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia".
2 are not yet recruiting,
9 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".